ROIVANT SCIENCES LTD. Increase (Decrease) in Other Current Assets
ROIVANT SCIENCES LTD. (ROIV) reported Increase (Decrease) in Other Current Assets of $23.84 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-06
- ROIVANT SCIENCES LTD. increase (decrease) in other current assets for the quarter ending 2026-06-30 was $23.84M.
- ROIVANT SCIENCES LTD. increase (decrease) in other current assets for the quarter ending 2026-03-31 was -$18.45M.
- ROIVANT SCIENCES LTD. increase (decrease) in other current assets for the quarter ending 2025-12-31 was $2.73M, a 93.45% decline year-over-year.
- ROIVANT SCIENCES LTD. increase (decrease) in other current assets for the quarter ending 2025-09-30 was $4.39M.
- ROIVANT SCIENCES LTD. increase (decrease) in other current assets for fiscal 2026 was -$11.46M, a 145.71% decline from fiscal 2025.
- ROIVANT SCIENCES LTD. increase (decrease) in other current assets for fiscal 2025 was $25.07M, a 69.23% decline from fiscal 2024.
- ROIVANT SCIENCES LTD. increase (decrease) in other current assets for fiscal 2024 was $81.48M, a 157.27% increase from fiscal 2023.
- ROIVANT SCIENCES LTD. increase (decrease) in other current assets for fiscal 2023 was $31.67M, a 13.11% increase from fiscal 2022.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.84M 10-Q · filed 2026-08-06 | $5.38M derived: sum of 2 quarters · filed 2026-08-06 | $8.12M derived: sum of 3 quarters · filed 2026-08-06 | $12.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$18.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | -$15.72M derived: sum of 2 quarters · filed 2026-05-20 | -$11.33M derived: sum of 3 quarters · filed 2026-05-20 | -$11.46M 10-K · filed 2026-05-20 |
| 2025-12-31 | $2.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $7.12M derived: sum of 2 quarters · filed 2026-02-06 | $7.00M 10-Q · filed 2026-02-06 | -$21.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | $4.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | $4.26M 10-Q · filed 2025-11-10 | -$24.59M derived: sum of 3 quarters · filed 2026-08-06 | $17.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$128.00K 10-Q · filed 2026-08-06 | -$28.98M derived: sum of 2 quarters · filed 2026-08-06 | $12.74M derived: sum of 3 quarters · filed 2026-08-06 | $8.61M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$28.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $12.86M derived: sum of 2 quarters · filed 2026-05-20 | $8.74M derived: sum of 3 quarters · filed 2026-05-20 | $25.07M 10-K · filed 2026-05-20 |
| 2024-12-31 | $41.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $37.59M derived: sum of 2 quarters · filed 2026-02-06 | $53.92M 10-Q · filed 2026-02-06 | $116.63M derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-09-30 | -$4.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | $12.21M 10-Q · filed 2025-11-10 | $74.92M derived: sum of 3 quarters · filed 2026-05-20 | $67.41M derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-06-30 | $16.33M 10-Q · filed 2025-08-11 | $79.05M derived: sum of 2 quarters · filed 2026-05-20 | $71.53M derived: sum of 3 quarters · filed 2026-05-20 | $93.17M derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-03-31 | $62.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $55.20M derived: sum of 2 quarters · filed 2026-05-20 | $76.84M derived: sum of 3 quarters · filed 2026-05-20 | $81.48M 10-K · filed 2026-05-20 |
| 2023-12-31 | -$7.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-10 | $14.13M derived: sum of 2 quarters · filed 2025-02-10 | $18.77M 10-Q · filed 2025-02-10 | $19.40M derived: sum of 4 quarters · filed 2025-05-29 |
| 2023-09-30 | $21.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-12 | $26.28M 10-Q · filed 2024-11-12 | $26.91M derived: sum of 3 quarters · filed 2025-05-29 | $27.73M derived: sum of 4 quarters · filed 2025-05-29 |
| 2023-06-30 | $4.64M 10-Q · filed 2024-08-09 | $5.27M derived: sum of 2 quarters · filed 2025-05-29 | $6.09M derived: sum of 3 quarters · filed 2025-05-29 | $24.99M derived: sum of 4 quarters · filed 2025-05-29 |
| 2023-03-31 | $633.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $1.45M derived: sum of 2 quarters · filed 2025-05-29 | $20.36M derived: sum of 3 quarters · filed 2025-05-29 | $31.67M 10-K · filed 2025-05-29 |
| 2022-12-31 | $818.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-13 | $19.72M derived: sum of 2 quarters · filed 2024-02-13 | $31.04M 10-Q · filed 2024-02-13 | $42.97M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-09-30 | $18.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | $30.22M 10-Q · filed 2023-11-13 | $42.15M derived: sum of 3 quarters · filed 2023-11-13 | |
| 2022-06-30 | $11.31M 10-Q · filed 2023-08-14 | $23.25M derived: sum of 2 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $11.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-28 | $28.00M 10-K · filed 2023-06-28 | ||
| 2021-12-31 | $16.06M 10-Q · filed 2023-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |